Bimagruma may be your next choice
Bimagruma may be your next choice Read More »
Currently, GLP-1 therapies dominate the weight-loss drug market, achieving 20%–25% weight reduction within a year while continually pushing the upper limits of weight loss. However, research indicates that approximately 30-40% of weight loss from GLP-1 drugs like semaglutide stems from muscle loss. This may lead to reduced metabolic rates and increased risk of weight regain. […]